Literature DB >> 22711564

Sphingosine-1-phosphate activates chemokine-promoted myeloma cell adhesion and migration involving α4β1 integrin function.

David García-Bernal1, Javier Redondo-Muñoz, Ana Dios-Esponera, Raphaël Chèvre, Elvira Bailón, Mercedes Garayoa, Nohemí Arellano-Sánchez, Norma C Gutierrez, Andrés Hidalgo, Angeles García-Pardo, Joaquin Teixidó.   

Abstract

Myeloma cell adhesion dependent on α4β1 integrin is crucial for the progression of multiple myeloma (MM). The α4β1-dependent myeloma cell adhesion is up-regulated by the chemokine CXCL12, and pharmacological blockade of the CXCL12 receptor CXCR4 leads to defective myeloma cell homing to bone marrow (BM). Sphingosine-1-phosphate (S1P) regulates immune cell trafficking upon binding to G-protein-coupled receptors. Here we show that myeloma cells express S1P1, a receptor for S1P. We found that S1P up-regulated the α4β1-mediated myeloma cell adhesion and transendothelial migration stimulated by CXCL12. S1P promoted generation of high-affinity α4β1 that efficiently bound the α4β1 ligand VCAM-1, a finding that was associated with S1P-triggered increase in talin-β1 integrin association. Furthermore, S1P cooperated with CXCL12 for enhancement of α4β1-dependent adhesion strengthening and spreading. CXCL12 and S1P activated the DOCK2-Rac1 pathway, which was required for stimulation of myeloma cell adhesion involving α4β1. Moreover, in vivo analyses indicated that S1P contributes to optimizing the interactions of MM cells with the BM microvasculture and for their lodging inside the bone marrow. The regulation of α4β1-dependent adhesion and migration of myeloma cells by CXCL12-S1P combined activities might have important consequences for myeloma disease progression.
Copyright © 2012 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22711564     DOI: 10.1002/path.4066

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  16 in total

1.  In vivo adhesion of malignant B cells to bone marrow microvasculature is regulated by α4β1 cytoplasmic-binding proteins.

Authors:  M Martínez-Moreno; M Leiva; N Aguilera-Montilla; S Sevilla-Movilla; S Isern de Val; N Arellano-Sánchez; N C Gutiérrez; R Maldonado; J Martínez-López; I Buño; J A García-Marco; P Sánchez-Mateos; A Hidalgo; A García-Pardo; J Teixidó
Journal:  Leukemia       Date:  2015-12-10       Impact factor: 11.528

2.  Sphingosine 1-phosphate (S1P) receptors 1 and 2 coordinately induce mesenchymal cell migration through S1P activation of complementary kinase pathways.

Authors:  Patrick Quint; Ming Ruan; Larry Pederson; Moustapha Kassem; Jennifer J Westendorf; Sundeep Khosla; Merry Jo Oursler
Journal:  J Biol Chem       Date:  2013-01-07       Impact factor: 5.157

3.  Inhibition of sphingosine kinase 2 downregulates the expression of c-Myc and Mcl-1 and induces apoptosis in multiple myeloma.

Authors:  Jagadish Kummetha Venkata; Ningfei An; Robert Stuart; Luciano J Costa; Houjian Cai; Woodrow Coker; Jin H Song; Kiwana Gibbs; Terri Matson; Elizabeth Garrett-Mayer; Zhuang Wan; Besim Ogretmen; Charles Smith; Yubin Kang
Journal:  Blood       Date:  2014-09-18       Impact factor: 22.113

4.  Systematic analysis of berberine-induced signaling pathway between miRNA clusters and mRNAs and identification of mir-99a ∼ 125b cluster function by seed-targeting inhibitors in multiple myeloma cells.

Authors:  Maoxiao Feng; Xiaochuang Luo; Chunming Gu; Yumin Li; Xuejiao Zhu; Jia Fei
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

5.  The effect of S1P receptor signaling pathway on the survival and drug resistance in multiple myeloma cells.

Authors:  Di Fu; Yingchun Li; Jia Li; Xiaoyan Shi; Ronghui Yang; Yuan Zhong; Huihan Wang; Aijun Liao
Journal:  Mol Cell Biochem       Date:  2016-10-27       Impact factor: 3.396

Review 6.  Role of Sphingolipids in Multiple Myeloma Progression, Drug Resistance, and Their Potential as Therapeutic Targets.

Authors:  Daniela N Petrusca; Kelvin P Lee; Deborah L Galson
Journal:  Front Oncol       Date:  2022-06-08       Impact factor: 5.738

7.  EphA3 targeting reduces in vitro adhesion and invasion and in vivo growth and angiogenesis of multiple myeloma cells.

Authors:  Francesco La Rocca; Irma Airoldi; Emma Di Carlo; Pina Marotta; Geppino Falco; Vittorio Simeon; Ilaria Laurenzana; Stefania Trino; Luciana De Luca; Katia Todoerti; Oreste Villani; Martin Lackmann; Fiorella D'Auria; Francesco Frassoni; Antonino Neri; Luigi Del Vecchio; Pellegrino Musto; Daniela Cilloni; Antonella Caivano
Journal:  Cell Oncol (Dordr)       Date:  2017-07-18       Impact factor: 6.730

8.  Integrin α4β1 controls G9a activity that regulates epigenetic changes and nuclear properties required for lymphocyte migration.

Authors:  Xiaohong Zhang; Peter C Cook; Egor Zindy; Craig J Williams; Thomas A Jowitt; Charles H Streuli; Andrew S MacDonald; Javier Redondo-Muñoz
Journal:  Nucleic Acids Res       Date:  2015-12-10       Impact factor: 16.971

Review 9.  Therapeutic potential of targeting sphingosine kinases and sphingosine 1-phosphate in hematological malignancies.

Authors:  C Evangelisti; C Evangelisti; F Buontempo; A Lonetti; E Orsini; F Chiarini; J T Barata; S Pyne; N J Pyne; A M Martelli
Journal:  Leukemia       Date:  2016-07-27       Impact factor: 11.528

10.  ETS-1-mediated transcriptional up-regulation of CD44 is required for sphingosine-1-phosphate receptor subtype 3-stimulated chemotaxis.

Authors:  Wenliang Zhang; Jiawei Zhao; Jen-Fu Lee; Allison Gartung; Hiba Jawadi; Wanyu Louis Lambiv; Kenneth V Honn; Menq-Jer Lee
Journal:  J Biol Chem       Date:  2013-09-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.